Detalhe da pesquisa
1.
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.
Lancet Oncol
; 25(6): 779-789, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701815
2.
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
Mod Pathol
; 37(3): 100423, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191122
3.
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 468-482, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080223
4.
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Br J Cancer
; 128(7): 1360-1368, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690721
5.
Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors.
Invest New Drugs
; 39(6): 1587-1597, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34180037
6.
Improving survival from metastatic, recurrent, or persistent cervical cancer.
Lancet
; 403(10421): 2-4, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048788
7.
The challenge of improving outcomes in locally advanced cervical cancer.
Lancet Oncol
; 24(12): 1289-1291, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039987
8.
Adjuvant chemotherapy for locally advanced cervical cancer - Authors' reply.
Lancet Oncol
; 24(7): e290, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414018
9.
Cervical cancer: A global health crisis.
Cancer
; 123(13): 2404-2412, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28464289
10.
Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer.
Int J Gynecol Cancer
; 27(5): 900-906, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28498256
11.
Prediction of recurrence risk in endometrial cancer with multimodal deep learning.
Nat Med
; 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38789645
12.
Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.
Lancet Digit Health
; 5(2): e71-e82, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36496303
13.
Tertiary lymphoid structures critical for prognosis in endometrial cancer patients.
Nat Commun
; 13(1): 1373, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296668
14.
HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes.
Cancers (Basel)
; 13(1)2020 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375706
15.
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
J Clin Oncol
; 38(29): 3388-3397, 2020 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32749941
16.
Stories of the music of hope.
Med J Aust
; 196(4): 276-7, 2012 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22409696
17.
Developing an Evidence-Based, Nurse-Led Psychoeducational Intervention With Peer Support in Gynecologic Oncology.
Cancer Nurs
; 39(2): E19-30, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-25881806
18.
Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors.
J Clin Oncol
; 30(13): 1527-33, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22454420
19.
Improvement of Outcomes for Women With HIV Infection and Cervical Cancer.
J Clin Oncol
; 34(31): 3719-3721, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27573654